The method of preparing couples for pregnancy

 

(57) Abstract:

The invention relates to medicine, in particular to obstetrics, and for measures aimed at improving the reproductive health of the population. When preparing couples for pregnancy within two months before the planned pregnancy both spouses enter trivet and vobenzim. The method allows to reduce the number of cases of pathologically leaked pregnancy and childbirth, to reduce early neonatal mortality.

The present invention relates to medicine, namely to obstetrics, and can be used to prepare spouses for pregnancy.

Relevance:

Currently, Russia has been a trend to deterioration in the health of the population of young people; 85-98% entered actively in fertile age suffer from various kinds of extragenital pathology, reproductive health disorders. Of particular importance is the quality of the health of the newly born generations of children, dependent parents health. The high prevalence of chronic diseases in women, unfavourable pregnancy, childbirth and the postpartum period create closed who have accumulated enough information about the role of proteins of the reproductive system of the father in violation of the pregnancy, the health status of children. Pathological indicators of placental alpha-2-microglobulin (PAMG-2) sperm of the father revealed the low level of health of children, characterized by physical disabilities, developmental neuro-psychical development, greater severity of neurological disorders [7]. In modern conditions of living infertility, the frequency of threatened abortion, early and late preeclampsia, preterm delivery, fetal hypotrophy, disease of the newborn and perinatal mortality are markers of ecological trouble [1, 2].

Analogues of the proposed method are:

1. The way pregravidarnoy training couples identified at the planning stage of pregnancy chronic intrauterine infection, including use in combination with anti-bacterial metabolic, immunostimulating therapy [6]. But this method is only applied where identified chronic intrauterine infection, not taking into account the impact of other factors.

2. The application course of preventive therapy, including antioxidants - vitamin E, ascorbic acid, glutamic acid; iron preparations - veraplex or ferramic; chelators - poly is substance abuse problems [3]. These courses are recommended during pregnancy only woman, not taking into account the initial state of the reproductive system of the spouses before pregnancy.

Also known is a set of measures to prevent early formation of placental insufficiency in women of high environmental risk [4] . The complex includes vitamins and drugs that have a stabilizing effect, which increase nonspecific resistance of the organism. However, this complex is aimed at preparing for pregnancy women, not taking into account the health condition of her husband, which reduces its effectiveness.

In recent years for the treatment of preeclampsia is used immunomodulatory, membrane preparation WOBENZYM aimed at normalizing blood rheological properties [5] , that is used in the preparation already in complicated pregnancy.

The invention

The aim of the invention is the prevention of pregnancy complications associated with altered reactivity of the spouses.

The method is as follows: 2 months before the planned pregnancy both spouses prescribe medication WOBENZYM to 3 pills 3 times a day for 40 min, eliminating immune complexes, improves blood rheology, normalize lipid metabolism, stabilizing the cell membrane. At the same time spend a vitamin drug TRIVET (vitamin A, C, E and Se), which is administered 1 capsule 1 time a day for 2 months. TRIVET and increases the overall immune resistance, stabilizes the cell membrane protects the cell from the damaging effects of free radicals.

The claimed method was prepared for pregnancy 40 couples that have helped to reduce the frequency of the threat of miscarriage 37.6%; the frequency of the threat of premature birth by 46.6%; preterm delivery 8.3%; swollen-hypertensive form of preeclampsia (OG-gestosis) 20%; chronic fetoplacental insufficiency (hfpn) subcompensated form by 5.8%; early neonatal mortality by 1.6%; the birth of children with weight less than 2500 g is 9.8%. Increased by 30% the birth of children with rating on a scale of Apgar at 1 minute 7 or more points. 21.6% decrease in the number of children born with signs of intrauterine infection.

Example 1. Myasnikova O. C., age 28, living for 28 years with her husband, Ekaterinburg. From the anamnesis: the first pregnancy ended urgent rodamaal complete clinical and laboratory examination. When examining somatic and reproductive pathology has not been found and spouses was recommended medical complex pregravidarnoy training. Recommendations have not been implemented and pregnancy. With small time there was a threat of termination and, in spite of preserving therapy in 8 weeks occurred a spontaneous miscarriage. After that, the couple was guarded during the year, then spent medication pregravidarnoy training and only then planned a desired pregnancy. The pregnancy was uneventful. Odoratissimus the term full-term pregnancy child on 8/8 points on the Apgar scale and on the fifth day the mother and child in a satisfactory condition were discharged home.

Example 2. Korzhevskii L. P. , 36 years old, lived in throughout your life together with her husband, in Yekaterinburg. From the anamnesis: the first pregnancy ended in 1993, medical abortion, without complication. Then within 4 years was not guarded and not pregnant. In 1997, together with her husband underwent clinical and laboratory examination at the planning stage of pregnancy. Of somatic pathology in women with chronic cholecystitis in remission, reproductive is e which immediately came a desired pregnancy. The pregnancy was uneventful. On the totality of evidence ("immature" vaginally, age perforada) term full-term pregnancy was rodorazresheniye way cesarean sections. The baby was born on 7/8 points on the Apgar scale.

Conclusion:

Thus, pregravidarnaya training spouses preparation WOBENZYM 2 months before planned pregnancy reduces the incidence of threatened miscarriage 37.6%; the frequency of the threat of premature birth by 46.6%; preterm delivery 8.3%; swollen-hypertensive form of preeclampsia (OG-gestosis) 20%; chronic fetoplacental insufficiency (hfpn) subcompensated form by 5.8%; early neonatal mortality by 1.6%; the birth of children with weight less than 2500 g is 9.8%.

Sources of information taken into account in the examination

1. Ailamazyan E. K., Belyaeva I.e., Vinogradov E., the Influence of environmental conditions on the reproductive health of women. A new look at the problem. // Herald of the Russian Association of obstetricians and gynecologists. - 1996. - N 2. - S. 13-16.

2. Baranov A. A. children's Health Russia. - M., 1999. - 273 C.

3. Lineva O. I. , Gylmiarova F. N., Spiridonova N. In. Pathogenetic basis of prevention of gestosis in terms of E. T. B. Preventing early formation of placental insufficiency in pregnant women in the context of ecological risk //Actual problems of reproduction of the family. - Ekaterinburg, 1997. - S. 59-77.

5. Repin M. A. Systemic enzyme therapy in obstetrics and gynecology. - St. Petersburg, 1996. - 42 S.

6. Fedorova, M. C., Serov, C. N., The Summary A. N., Tareeva So, Intrauterine infection // Herald of the Russian Association of obstetricians and gynecologists, 1997. - N 2. - S. 89-99.

7. Moiseeva L. C., Bowl I. C., Shulgin E. A. Role of proteins of the reproductive system of the father in the formation of the child's health //the Materials of the Congress of pediatricians of Russia "Healthy child" (Moscow, February 16-18, 1999). - Moscow, 1999. - S. 365.

The method of preparing couples for pregnancy by taking vitamin therapy, characterized in that both spouses undergo pregravidarnoy training within two months, including vitamin complex Trivet" and immuno-modulating and stabilizing drug "Wobenzym".

 

Same patents:
The invention relates to medicine, in particular for secondary prevention post-radiation impaired spermatogenesis, and can be used in medical and health institutions
The invention relates to the field of medicine

The invention relates to new naphtylpropionate F.-ly (I), where R1and R2- N, -HE or-O(C1-C4-alkyl); R3- 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholinyl, dialkylamino - or 1-hexamethylen-aminogroup; n = 2 or 3, or pharmaceutically acceptable salts

The invention relates to medicine, namely to andrology, reproductive science

The invention relates to new niftystories compounds of formula I, where R1and R2- H, -OH, -O(C1-C4alkyl), -OCOC6H5, -OCO(C1-C6alkyl), -OSO2(C4-C6alkyl); R3- 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, 1 hexamethyleneimino; intermediate compounds, which are suitable for easing symptoms of postmenopausal syndrome, including osteoporosis, hyperlipemia and estrogenzawisimy cancer, and inhibition of uterine fibroids, endometriosis and proliferation of aortic smooth muscle cells

The invention relates to the field of medicine and relates to a pharmaceutical combination preparation for hormonal contraception

The invention relates to the field of medicine and relates to a pharmaceutical combination preparation of the two, Packed in spatial terms separately in the same packaging unit, intended for oral administration at a time sequentially hormonal components, which consist, depending on the circumstances, placed in spatial terms separately in one packing unit and retrieved separately daily dosing units, and the first hormonal component as hormonal biologically active substance contains a combination of estrogen and at least sufficient to suppress ovulation dosage gestagenna the drug either in-phase or multi-phase execution, and the second hormonal component as hormonal biologically active substance contains only one estrogen drug, and the first hormonal component covers 23 or 25, and the second hormonal component covers 4-10 daily dosing units, daily dosage units of the first hormonal component does not contain a combination of biogenic estrogen and synthetic estrogen, and the total number of daily dosing
The invention relates to medicine, in particular to the gynecologist, and for the treatment of oligomenorrhea in adolescent girls

The invention relates to medicine, namely to dermatology
The invention relates to medicine, namely to obstetrics, and can be used for prevention of placental insufficiency in terms of perinatal viral and bacterial infection
The invention relates to medicine, namely to rheumatology, and is intended for the treatment of rheumatoid arthritis

The invention relates to surgery
The invention relates to medicine, obstetrics

The invention relates to medicine, namely to dentistry

The invention relates to medicine, namely to therapy, and can be used in the treatment of malnutrition
The invention relates to medicine, namely to methods for treating chronic polymyositis

The invention relates to medicine and is a method of treating scar-modified tissue drug "Morical"

The invention relates to medicine and relates to a means for relief of alcohol withdrawal syndrome
Up!